FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA HIDRADENITIS SUPPURATIVA TRIAL Marks the start of the second Phase IIa trial to evaluate first-in-class monoclonal antibody CIT-013 this year, following the ...
Galderma opens up new chapter for Sculptra with MDR certification and new expanded indication for body: Zug, Switzerland Monday, December 8, 2025, 12:00 Hrs [IST] Galderma, the pu ...
Spinal Cord Injury (SCI) is a devastating neurological disorder that often leads to permanent neural dysfunction. Current treatments fail to address ...
Morning Overview on MSN
AI now decodes sweat to spot early signs of disease
Sweat is turning into one of medicine’s most revealing data streams, and artificial intelligence is learning how to read it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback